manappuram – Katalyst Wealth

7th Aug’20 – Jun’20 earnings update on Manappuram and Aarti Drugs

August 7, 2020

Dear Members, We have released 7th Aug’20 – Jun’20 earnings update on Manappuram Finance and Aarti Drugs. The same has been produced below. For other updates, please refer the following link – https://katalystwealth.com/category/latest-updates/ Date: 7th Aug’20 Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha stock CMP – 161.60 (BSE); 161.60 (NSE) Rating – Positive – 8% weightage; this is not an investment advice (refer rating interpretation) Source: bseindia.com Manappuram has reported decent set of numbers for Q1 FY 21; however,…

[Stock idea]: Manappuram Finance – 2nd largest Gold loan NBFC in India

November 6, 2019

Dear Sir, We have covered Manappuram Finance (NSE Code – MANAPPURAM) for our Premium members. It’s also part of our Model sheet. Since our initial coverage on the stock in Jul’17, the company has witnessed the worst of NBFC crisis in India and has emerged stronger. The company is primarily into short term gold loan business and on the back of positive ALM (asset liability mis-match) it could handle the crisis better. Currently, the company is doing well and unlike…

Manappuram Finance (NSE – MANAPPURAM) – Jul’17 Alpha/Alpha Plus stock

July 23, 2017

Dear Members, We have released 23rd Jul’17: Manappuram Finance Ltd (NSE Code – MANAPPURAM) – Alpha/Alpha Plus stock for Jul’17. For details and other updates, please log into the website at the following link – https://katalystwealth.com/index.php/my-account/ Detailed pdf report on the company can be accessed at the following link – Manappuram Finance (NSE Code – MANAPPURAM) – Jul17 Katalyst Wealth Alpha Report Date: 23rd Jul’17 CMP – 104.80 (BSE); 104.85 (NSE) Rating – Positive – 4% weightage; this is not an investment advice (refer rating…